Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale President & CEO sold 6,752 shares at an average $1.67 ($11,258)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale President & CEO sold 5,491 shares at an average $1.13 ($6,190)
  10. 4 Open-market sale Head of Research & Development sold 5,500 shares at $1.07 ($5,900)
  11. 4 Open-market sale Director sold 18,500 shares at $1.05 ($19,475)
  12. 4 Open-market sale Director sold 18,500 shares at $1.05 ($19,477)
  13. 4 Open-market sale Director sold 14,800 shares at $1.05 ($15,581)
  14. 4 Open-market sale Director sold 14,800 shares at $1.05 ($15,587)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 24 · 475 filings